Pharmaceutical Fraud

State and Federal Whistleblower laws award substantial compensation to individuals who have unique and direct information about pharmaceutical fraud. Strict laws and regulations govern the practices of pharmaceutical manufacturers, especially those receiving government funds through programs such as Medicare and Medicaid. Pharmaceutical fraud can take many forms, including off-label marketing of drugs, illegal kickbacks, and price inflation.

The False Claims Act contains a Whistleblower (qui-tam) provision that provides a strong incentive for individuals with knowledge of pharmaceutical fraud to come forward with their information. Under the Whistleblower provision of this Act, the individual reporting such knowledge may collect up to 30% percent of the damages recovered. Considering that monetary penalties can be in the tens of millions of dollars, whistleblower payouts can be quite substantial. In addition to encouraging individuals to report negligent or dangerous practices, the whistleblower provision also encourages pharmaceutical workers to avoid the same.

The Law Firm of Altman & Altman has provided exceptional legal services throughout the Commonwealth for over 40 years. We have recovered millions of dollars in settlements and jury awards on behalf of our clients. Our firm has the resources necessary to litigate MA Pharmaceutical Whistleblower Lawsuits against large pharmaceutical manufacturers and companies.

Our highly skilled Pharmaceutical Fraud Whistleblower Lawyers represent clients with information concerning all types of pharmaceutical fraud, including:

• Best Price Fraud
• Manufacturing / Distribution of Compound Drugs
• Good Manufacturing Practice (GMP) Violations
• Off-Label Marketing
• Pharmaceutical Kick-Backs

One of the more common forms of Pharmaceutical Fraud, off-label marketing occurs when a company markets a medication for uses other than those approved by the Food and Drug Administration (FDA) and receives government subsidies for such medication. While it is not illegal for medications to be used for off-label purposes, pharmaceuticals prescribed for off-label uses may not be subsidized or reimbursed by the government if the uses are not FDA approved. Thus, if these pharmaceuticals are billed to Medicare or Medicaid, fraud has been committed. If you have knowledge of Pharmaceutical Off-Label Marking Fraud, you may be entitled to a Whistleblower Award under the qui-tam provision of the False Claims Act.

Whistleblower Rewards through qui-tam actions are also available for individuals coming forward with information relating to Pharmaceutical Kick-Backs. Such arrangements are prohibited under a Federal law known as the “Anti-Kick-Back Statute.”

The “Anti-Kick-Back Statute” is violated when a pharmaceutical company offers money or any other incentive to physicians and/or hospitals in exchange for prescribing their product to patients. The law is also violated when a physician or hospital accepts such an incentive. The Anti-Kick-Back Statute aims to deter healthcare providers from basing their medical decisions on kick-backs rather than on what is best for the patient they are treating.

If you are aware of any type of Pharmaceutical Fraud, you may be entitled to a substantial percentage of the financial recovery under the False Claims Act Whistleblower provision. If you have questions about how to report this type of fraud, Contact the Law Firm of Altman & Altman to schedule a Free Initial Consultation with one of our experienced pharmaceutical fraud attorneys. We will examine all aspects of your Qui-Tam Claim and will walk you through the entire process. Our phones are answered 24 hours a day, seven days a week. All emails received by the firm are responded to immediately. The Law Firm of Altman & Altman represents all Pharmaceutical Fraud Whistleblower clients. In addition, all calls are handled in strict confidence.